Skip to content
OpenCapital
Get started

CareDx CDNA Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
——

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+35.7%
Enterprise value$1.35B+38.3%
P/S3.4×+0.4×

Profitability

See full
Gross margin65.5%—
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
CareDx (CDNA) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of $13K in Q1 2026.
How has CareDx's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?
CareDx's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash increased by 116.9% year-over-year, from -$77K to $13K.
What is the long-term trend for CareDx's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
Over 2 years (2021 to 2025), CareDx's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash has grown at a -43.7% compound annual growth rate (CAGR), from -$303K to -$96K.